Cargando…

Plasma PCSK9 levels are significantly modified by statins and fibrates in humans

BACKGROUND: Proprotein convertase subtilisin kexin-like 9 (PCSK9) is a secreted glycoprotein that is transcriptionally regulated by cholesterol status. It modulates levels of circulating low density lipoprotein cholesterol (LDLC) by negatively regulating low density lipoprotein receptor (LDLR) level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mayne, Janice, Dewpura, Thilina, Raymond, Angela, Cousins, Marion, Chaplin, Anna, Lahey, Karen A, LaHaye, Stephen A, Mbikay, Majambu, Ooi, Teik Chye, Chrétien, Michel
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2432057/ https://www.ncbi.nlm.nih.gov/pubmed/18547436 http://dx.doi.org/10.1186/1476-511X-7-22

Ejemplares similares

Differential effects of PCSK9 loss of function variants on serum lipid and PCSK9 levels in Caucasian and African Canadian populations
por: Mayne, Janice, et al.
Publicado: (2013)

Quercetin-3-glucoside increases low-density lipoprotein receptor (LDLR) expression, attenuates proprotein convertase subtilisin/kexin 9 (PCSK9) secretion, and stimulates LDL uptake by Huh7 human hepatocytes in culture
por: Mbikay, Majambu, et al.
Publicado: (2014)

The enigma of soluble LDLR: could inflammation be the key?
por: Mbikay, Majambu, et al.
Publicado: (2020)

Human Serum PCSK9 Is Elevated at Parturition in Comparison to Nonpregnant Subjects While Serum PCSK9 from Umbilical Cord Blood is Lower Compared to Maternal Blood
por: Peticca, Patricia, et al.
Publicado: (2013)

Comparing expression and activity of PCSK9 in SPRET/EiJ and C57BL/6J mouse strains shows lack of correlation with plasma cholesterol()
por: Sirois, Francine, et al.
Publicado: (2016)

Association of the rs562556 PCSK9 Gene Polymorphism with Reduced Mortality in Severe Malaria among Malian Children
por: Fedoryak, Olesya, et al.
Publicado: (2020)

Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize
por: Mbikay, Majambu, et al.
Publicado: (2022)

PCSK9 and triglyceride-rich lipoprotein metabolism
por: Druce, Irena, et al.
Publicado: (2015)

β‐Estradiol results in a proprotein convertase subtilisin/kexin type 9‐dependent increase in low‐density lipoprotein receptor levels in human hepatic HuH7 cells
por: Starr, Amanda E., et al.
Publicado: (2015)

Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review
por: Mbikay, Majambu
Publicado: (2012)

Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children
por: Arama, Charles, et al.
Publicado: (2018)

Statins and Fibrates for Diabetic Retinopathy: Protocol for a Systematic Review
por: Mozetic, Vania, et al.
Publicado: (2017)

Statins and/or fibrates for diabetic retinopathy: a systematic review and meta-analysis
por: Mozetic, Vânia, et al.
Publicado: (2019)

Ascorbic Acid Significantly Decreases Creatine Kinase Plasma Levels in an Animal Model of Statin/Fibrate-Induced Myopathy
por: Zabihi, Mohsen, et al.
Publicado: (2021)

Lagrangian Fibrations
por: Huybrechts, D., et al.
Publicado: (2022)

Which is the best lipid-modifying strategy in metabolic syndrome and diabetes: fibrates, statins or both?
por: Tenenbaum, Alexander, et al.
Publicado: (2004)

Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid
por: Moutzouri, Elisavet, et al.
Publicado: (2010)

Classifying spaces and fibrations
por: May, J Peter
Publicado: (1975)

Fibrations in CICY Threefolds
por: Anderson, Lara B., et al.
Publicado: (2017)

Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
por: Alagona, Peter
Publicado: (2010)

Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?
por: Morel, Jerome, et al.
Publicado: (2014)

Elucidating the Effects of the Lipids Regulators Fibrates and Statins on the Health Status of Finfish Species: A Review
por: Blonç, Manuel, et al.
Publicado: (2023)

SUN-071 Unexpected Paradoxical Extremely Low of HDL-Cholesterol Level in a Non-Diabetes, Non-CKD Patient after Treatment with Specific Fibrate and Statin and Specific Fibrate Alone
por: Kiatpanabhikul, Phatharaporn
Publicado: (2019)

Cardiovascular Events in Patients Received Combined Fibrate/Statin Treatment versus Statin Monotherapy: Acute Coronary Syndrome Israeli Surveys Data
por: Tenenbaum, Alexander, et al.
Publicado: (2012)

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
por: Chan, Sammy Y, et al.
Publicado: (2008)

Reporting quality and adherence of randomized controlled trials about statins and/or fibrates for diabetic retinopathy to the CONSORT checklist
por: Mozetic, Vânia, et al.
Publicado: (2019)

Distinguishing Elliptic Fibrations with AI
por: He, Yang-Hui, et al.
Publicado: (2019)

Torus fibrations, gerbes, and duality
por: Donagi, Ron, et al.
Publicado: (2008)

U-branes and $T^3$ fibrations
por: Liu, James T., et al.
Publicado: (1997)

The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome
por: Li, Xiang-ping, et al.
Publicado: (2013)

Comparison of pleiotropic effects of statins vs fibrates on laboratory parameters in patients with dyslipidemia: A retrospective cohort study
por: Takeuchi, Satoshi, et al.
Publicado: (2020)

Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
por: Kumar, Shoba Sujana, et al.
Publicado: (2009)

Update on the use of fibrates: focus on bezafibrate
por: Goldenberg, Ilan, et al.
Publicado: (2008)

D-Branes on K3-Fibrations
por: Kaste, P., et al.
Publicado: (1999)

On C(ℵ)-Fibrations in Bitopological Semigroups
por: Dawood, Suliman, et al.
Publicado: (2014)

The efficacy of Ezetimibe added to ongoing Fibrate-Statin therapy on postprandial lipid profile in the patients with type 2 Diabetes mellitus
por: Sharifi, Faranak, et al.
Publicado: (2013)

Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
por: Choi, Jah Yeon, et al.
Publicado: (2019)

Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
por: LaFratte, Christopher, et al.
Publicado: (2023)

Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials
por: Blais, Joseph E., et al.
Publicado: (2021)

Confirmation of Statin and Fibrate Use from Small-Volume Archived Plasma Samples by High-Throughput LC-MS/MS Method
por: Kusovschi, Jennifer D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0bqgmq3jdkqu39qj0oobnc97lr